Summit Is Accelerating Clinical Development of Ivonescimab » Pr Newswire - New Mobile Phones, Laptops, Gadgets Technology News

Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab

Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab

...